Add like
Add dislike
Add to saved papers

Abscisic acid treatment alleviates cadmium toxicity in purple flowering stalk (Brassica campestris L. ssp. chinensis var. purpurea Hort.) seedlings.

The aim of this research was to investigate how exogenous abscisic acid (ABA) alleviates cadmium (Cd) toxicity in purple flowering stalk (Brassica campestris L. ssp. chinensis) and evaluate whether it could be a potential choice for phytoremediation. Purple flowering stalk seedlings were cultivated in a hydroponic system with Cd at various concentrations (0-100 μmol L-1 ) as controls and Cd plus ABA as the treatment in the growth media. The soluble proteins, chlorophyll contents and the activity of the antioxidant enzyme system were determined by previously established biochemical methods. The contents of soluble protein and chlorophyll, and the activities of superoxide dismutase (SOD, EC 1. 15.1.1), peroxidase (POD, EC 1.11.1.7), ascorbic peroxidase (APX, EC 1.11.1.11), glutathione reductase (GR, EC 1.8.1.7) and superoxide anion (O2·- ) increased with the increase of external Cd concentrations, and then decreased in both Cd and Cd+ABA treatments, with higher activities of enzymes but lower level of O2·- in Cd+ABA than those in Cdonly treatments. It indicated that a stress adaptation mechanism was employed at lower Cd concentrations. The contents of malondialdehyde (MDA) and hydrogen peroxide (H2 O2 ), increased with the increase of Cd concentrations in the growth medium, with the highest levels in the treatment of 100 μmol L-1 Cd with lower levels in respective Cd+ABAtreatments than the Cd only treatmetns. Plants treated with 100 μmol L-1 Cd plus ABA showed a 60% decrease in Cd content in the leaves but a 259% increase in Cd content in the roots. In summary, exogenous ABA might alleviate Cd toxicity in purple flowering stalk mainly by reducing the reactive oxygen species (ROS) though activing the antioxidant enzyme system and accumulating more Cd in roots.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app